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Abstract
Actinomycetes are soil-dwelling Gram-positive bacteria, industrially relevant as
producers of a wide range of bioactive secondary metabolites, including many anti‐
biotics of clinical and commercial importance.
The understanding of actinomycete biology has been based on extensive studies on
the model organism Streptomyces coelicolor over many years and on the availability
of its complete genome sequence. This bacterium has an unusual complex develop‐
mental cycle that includes programmed cell death phenomena that make this bacte‐
rium a multicellular prokaryotic model.
Morphological differentiation in S. coelicolor is strictly related to physiological dif‐
ferentiation: indeed the onset of morphological differentiation generally coincides
with the production of secondary metabolites. During cell death, degradative pro‐
teins are synthesized and involved in an extensive degradation of some cellular
constituents (proteins and lipids) used for a second growth phase, that is accompa‐
nied by antibiotic production.
If on one hand, many factors with pleiotropic activity have been identified as key
players to control both morphological and physiological differentiation in S. coelicol‐
or, on the other hand, for most actinomycetes, mechanisms and factors governing
morphological and physiological processes have not been deeply investigated.
This chapter reviews the regulatory mechanisms known to control antibiotic pro‐
duction in actinomycetes and both genetic and physiological methods adopted to
improve antibiotic yields.
Keywords: Antibiotic production, Actinomycetes, genetic engineering, regulation,
heterologous expression
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1. Introduction
The discovery by Alexander Fleming of penicillin opened up a completely new era of chemo‐
therapy. Antibiotics have saved a large number of lives and also contributed to the increase in
life expectancy. They are mainly produced by the fermentation of fungi (e.g., Penicillium) and
bacteria (e.g., Actinomycetes). In particular, 80% of antibiotics are sourced from the genus
Streptomyces and rare actinomycetes, such as Actinomadura, and only the 20% is produced by
fungal species.
Actinomycetes are soil-dwelling Gram-positive bacteria that have extensive arsenals of
secondary metabolites, metabolism products that, differently from primary metabolites such
as vitamins, amino acids, nucleotides, etc., are not essential for the bacterial growth, at least in
laboratory conditions; indeed, many mutants in antibiotic biosynthesis have been generated
revealing that they are still vital and were used as models to understand molecular mecha‐
nisms governing antibiotic production.
Secondary metabolites include antitumorals (e.g., doxorubicin and bleomycin), antifungals
(e.g., amphotericin B and nystatin), immunosuppressives (e.g., FK-506 and rapamycin),
insecticides (e.g., spinosyn A and avermectin B), herbicides (e.g., phosphinotricin) and many
antibiotics of clinical and commercial importance.
This chapter reviews common regulatory mechanisms that control antibiotic production in
actinomycetes and both genetic and physiological methods to improve antibiotic yields.
2. Antibiotics and their targets
Antibiotics are molecules that selectively inhibit bacterial growth without damaging the
eukaryotic organisms. The selectivity of action of these substances is given by the fact that they
interfere with processes essential for the bacterial cell and absent or different in the eukaryotic
cell.
Antibiotics essentially target bacterial structures or functions, such as cell wall biosynthesis
(e.g., vancomycin), translation (e.g., streptomycin), RNA transcription (e.g., rifampicin), DNA
replication and synthesis (e.g., novobiocin and metronidazole), membrane (polimyxins), and
in general they inhibit bacterial growth (Figure 1).
Among the antibiotics that target the cell wall, glycopeptides are a class of drugs produced by
Actinomycetes and are composed of glycosylated cyclic or polycyclic non-ribosomal peptides.
Glycopeptides bind to the dipeptide D-alanyl--D-alanine (D-Ala-D-Ala) within the cell wall
of Gram-positive bacteria preventing the addition of new units to the peptidoglycan and
inhibiting the peptidoglycan synthesis. Significant glycopeptide antibiotics include the anti-
infective antibiotics vancomycin, teicoplanin, telavancin, ramoplanin, decaplanin, and the
antitumor antibiotic bleomycin. Vancomycin is used as antibiotic of last resort for infections
with methicillin-resistant Staphylococcus aureus. Toxigenic S. aureus strains can be isolated from
food making it an actual problem for public health [1].
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Cycloserin, produced by Streptomyces orchidaceus, is a cyclic analogue of D-alanine that acts
against two crucial enzymes important in the cytosolic stages of peptidoglycan synthesis:
alanine racemase and D-Ala-D-Ala ligase. When both of these enzymes are inhibited, D-
alanine residues cannot form and previously formed D-alanine molecules cannot be joined
together.
Penicillins  and  cephalosporins  are  the  most  important  antibiotics  obtained  from  fungi
Penicillium notatum and P. chrysogenum, respectively. Penicillins and cephalosporins mimic
the D-alanyl-D-alanine groups found at the terminus of the pentapeptide in most newly
synthesized peptidoglycan monomers. Binding of the drug to the transpeptidase inhibits the
formation of  cross-links  between the  rows and layers  of  peptidoglycan in  the  cell  wall.
Collectively,  this  results  in  degradation  of  the  peptidoglycan  and  osmotic  lysis  of  the
bacterium [2].
Many different classes of antibiotics block protein synthesis. Tetracycline (produced by
Streptomyces aureofaciens), for example, inhibits aminoacyl-tRNA binding, while chloramphe‐
nicol (Streptomyces venezuelae) and erythromycin (produced by Saccaropolyspora erythraea) bind
to 50S subunit, blocking the peptidyl transferase activity; kanamycin (produced by Streptomy‐
ces kanamyceticus) binds to 30S subunit; thiostrepton (produced by Streptomyces laurentii)
inhibits ribosome-dependent EF-Tu and EF-G GTPase, while streptomycin (produced by
Figure 1. Principal targets of antibiotics. The antibiotics produced by Actinomycetes and by fungi are indicated in blue
and red, respectively. The synthetic antibiotics are underlined.
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Streptomyces griseus) prevents formation of initiation complex by insertion of improper amino
acids.
Rifampicin is a semisynthetic antibiotic produced by the fermentation of a strain of Amycola‐
topsis mediterranei and it is a key component of anti-tuberculosis therapy. It inhibits the bacterial
RNA polymerase by binding a pocket of the RNAP β subunit within the DNA/RNA channel
and destabilizing the DNA-RNA polymerase-oligonucleotide-complexes [3].
Novobiocin, also known as albamycin or cathomycin, is an aminocoumarin antibiotic that is
produced by the actinomycete Streptomyces niveus. Novobiocin is a very potent inhibitor of
bacterial DNA gyrase and functions by targeting the GyrB subunit of the enzyme involved in
energy transduction [4–5].
Polymyxins are antibiotics produced by nonribosomal peptide synthetase systems in Gram-
positive bacteria, such as Paenibacillus polymyxa. Their structure consists of a cyclic peptide
with a long hydrophobic tail. They act by disrupting the structure of the bacterial cell mem‐
brane and interacting with its phospholipids [6].
A few antibiotics are produced by chemical synthesis (e.g., quinolone and metronidazole).
Quinolones are synthetic, bactericidal agents that inhibit the enzyme topoisomerase II, a DNA
gyrase necessary for the replication of the microorganism. Topoisomerase II enzyme produces
a negative supercoil on DNA, permitting transcription or replication; thus, by inhibiting this
enzyme, DNA replication and transcription are blocked.
Metronidazole is a synthetic compound used in the treatment of infections caused by Gram-
negative anaerobic bacteria and protozoa. It was shown to induce base-pair substitutions [7]
and to be a potent mutagen in bacteria and low eukaryotic systems [8].
3. Genetic organization of antibiotic biosynthesis
Genes involved in the biosynthesis of antibiotics and other secondary metabolites are typically
clustered within the respective genome or, rarely, in circular plasmid. A biosynthetic gene
cluster contains many genes, often located within a few thousand base pairs of each other that
encode for proteins participating in a metabolic pathway that leads to the production of a
particular secondary metabolite (Figure 2).
Figure 2. Schematic example of a gene cluster for antibiotic production. Different colors indicate different functions.
The size of gene clusters can vary significantly, from a few to several hundred genes. Com‐
monly, 10–50 genes are required for the synthesis of an antibiotic. A gene cluster usually
contains genes involved in the precursor biosynthesis, tailoring steps, export, resistance, and
regulation.
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Some peptide antibiotics are formed by amino acidic precursors that are then assembled by
non-ribosomal machinery. In the case of non-ribosomal peptide synthesis, non-proteinogenic
amino acids, such as 3,5-dihydroxyphenylglycine (DPG) and 4-hydroxyphenylglycine (HPG),
can be found. In many cases, the backbone of the antibiotic is modified by the so-called tailoring
steps, i.e., chlorination, methylation, glycosylation, N-acylation, and so on.
The polyketides are another class of natural antibiotics synthesized through the decarboxyla‐
tive condensation of malonyl-CoA-derived extender units in a process similar to the fatty acid
synthesis. The polyketide chains produced by a minimal polyketide synthase are often further
modified (e.g., glycosylated) into bioactive natural products.
Actinorhodin and undecylprodiginines are two of the antibiotics produced by S. coelicolor.
Actinorhodin is a red/blue pH-indicating benzoisochromanequinone made by a type II
polyketide synthase-based pathway, while undecylprodiginines are red hydrophobic tripyr‐
roles made by a fatty acid synthase-like.
Usually, a gene cluster for antibiotic production encodes for regulatory genes, named pathway
specific, with positive or negative control on the cluster. Moreover, there could be some
pleiotropic regulators that affect antibiotic production, morphological development, and
primary metabolism of the bacteria. As examples, actinorhodin biosynthesis is regulated by
the transcriptional activator ActII-ORF4 [9–10], while the undecylprodigiosin pathway is
regulated via a minicascade of two cluster specific regulators, with RedZ activating the
expression of redD, an aberrant orphan response regulator, direct activator gene for the
biosynthetic genes [11].
In the bacteria producers of antibiotics, resistance genes are necessary to avoid the suicide,
while transport genes are used to export the antibiotic outside the cell. Resistance to antibiotics
can be caused by several general mechanisms (Figure 3): increased efflux or decreased influx
of the antibiotic, target site alteration, target amplification, or antibiotic inactivation/modifi‐
cation [12].
The production of β-lactamase is a common mechanism found in many pathogens. This
enzyme is capable of hydrolyzing and destroying the β-lactam ring of the antibiotic avoiding
its antibacterial activity.
As example of alteration of the target site, the methylation of an adenine of the ribosomal RNA
prevents the interaction between macrolides and ribosome.
Resistance to glycopeptides is frequently due to the presence of genes encoding for enzymes
involved in the synthesis of alternative forms of peptidoglycan, with low affinity for glyco‐
peptides. For example, the C terminal D-Ala-D-Ala is replaced by D-Ala-D-Lac or D-Ala-D-
Ser [13]. Glycopeptide resistance has been explored in three different actinomycetes:
Streptomyces coelicolor, which does not produce glycopeptide, Streptomyces toyocaensis and
Actinoplanes teichomyceticus, which produce the glycopeptides A47934 and teicoplanin,
respectively. For the producers of glycopeptides, activation of the resistance genes by the
endogenously produced antibiotic prevents suicide, while in non-producing bacteria resist‐
ance may be due to genetic changes, such as mutation or acquisition of resistance genes through
Production of Antibacterial Compounds from Actinomycetes
http://dx.doi.org/10.5772/61525
181
horizontal transfer. In other systems, the antibiotic is acetylated by specific acetyl transferase
inactivating its antibacterial property [14–15].
The best known efflux system regards the tetracycline, the gene tetL, carried by a transposon,
codifies for a protein that transports the antibiotic outside the cell.
4. Morphological and physiological differentiation
Actinomycetes represent an important model of bacterial development; they display an
unusual complex life cycle with different cell types (spores, vegetative and reproductive
mycelium) and with the morphological changes strictly connected to the physiological
differentiation. The understanding of Actinomycetes biology has been based on extensive
studies on the model organism Streptomyces coelicolor over many years and on the availability
of its complete genome sequence [16]. S. coelicolor is considered a ‘‘multicellular’’ prokaryotic
model that includes programmed cell death and sporulation. After spore germination,
vegetative growth leads to formation of a mycelium consisting of a ramifying network of
syncytial hyphae that penetrate a moist substrate by extension of hyphal tips and subapical
branching (vegetative mycelium). Subsequent reproductive growth often proceeds with the
formation of filamentous aerial hyphae that eventually undergo differentiation into chains of
unigenomic spores (Figure 4). This complex developmental cycle includes programmed cell
death phenomena that make this bacterium a multicellular prokaryotic model [17–19].
Figure 3. Mechanisms of antibiotic resistance.
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Genetic studies of Streptomyces development regulation focused largely on analyses of S.
coelicolor mutant strains defective in different stages of development. The main studied strains
are the so-called "bald" mutants that are defective in aerial growth and the "white" mutants that
are defective in the formation of mature grey spores on the tips of the white aerial mycelium.
The bald mutants are affected in genes that regulate the ‘‘sky-pathway’’ that activates the
expression of genes encoding proteins forming hydrophobic cover, such as eight chaplin
proteins, RdlA, and Rdl rodlin proteins; the white genes are responsible of the formation of
grey spores [20–21].
Figure 4. The Streptomyces coelicolor life cycle.
Morphological differentiation in Actinomycetes is strictly related to physiological differentia‐
tion: indeed the onset of morphological differentiation generally coincides with the production
of secondary metabolites.
If on one hand, many factors with pleiotropic activity were identified as key players to control
both morphological and physiological differentiation in S. coelicolor, on the other hand, for
most actinomycetes, mechanisms and factors governing morphological and physiological
processes were not deeply investigated yet.
5. General approaches to overproduce natural antibiotic
Natural bacterial strains often produce only small amounts of antibiotic (µg/l), while produc‐
tion rates in the range of g/l are needed to set up a cost-effective production process. In order
to increase the industrial yield of products, different strategies can be adopted.
Random mutagenesis for the selection of overproducing mutants remains the preferred
method when molecular genetic tools have not been developed for the producer microorgan‐
ism. Although random mutagenesis and screening procedures have been widely used for
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genetic improvement of antibiotic production, there are certain disadvantages, such as the time
necessary to obtain a favorable mutation. The knowledge-driven genetic manipulation can
make the optimization of strains and conditions more efficient.
In general, many approaches have been used to improve antibiotic production as schematically
represented in Figure 5.
The tuning of media composition and fermentation conditions (carbon source, phosphate and
nitrogen concentrations, pH, temperature) and the supply of specific precursors are the first
approaches used in order to increase the yield in fermentation. Moreover, genetic manipula‐
tion of primary or secondary metabolism can be applied. Regarding primary metabolism,
mutations in pathways for amino acids or other molecules that are used as precursors in
antibiotic biosynthesis or mutations in the ribosome can improve indirectly the yield of
secondary metabolites.
Figure 5. Approaches used to improve the antibiotic production.
Regarding secondary metabolism, the over-expression of biosynthetic genes, such as the genes
that codify for antibiotic specific precursors, the over-expression of pathway-specific positive
regulators or the inactivation of pathway-specific negative regulators can result in an increase
of antibiotic yield. Increasing self-resistance levels in producing organisms has been also used
for improving production yields. Manipulation of pleiotropic regulators, involved in both
primary and secondary metabolisms, was also successfully used to improve antibiotic yields.
The production of antibiotics in some Streptomyces spp. depends upon diffusible butyrolactones
structurally similar to homoserine lactones. γ butyrolactones have been applied for improve‐
ment of secondary metabolite production.
6. Media composition effect on antibiotic production
In bacteria, several sugars can be used as carbon sources. Although glucose is often an excellent
carbon and energy source for microbial growth, it is infrequently utilized as the major carbon
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and energy source in secondary metabolite fermentation. When incubated in media containing
glucose and another carbon source, bacteria metabolize first glucose that represses the
transcription of genes required for the utilization of the secondary carbon sources. When
glucose is exhausted, the metabolism of the second carbon source is activated, and generally
this correlates with the onset of antibiotic production. This phenomenon is referred to as carbon
catabolite repression and is mediated via components of the phosphoenolpyruvate:carbohy‐
drate phosphotransferase system, which transports and phosphorylates carbohydrates.
Glucose repression in S. coelicolor was demonstrated to be dependent upon the formation of
intermediates of carbohydrate catabolism, for example, fructose 1,6-diphosphate and glucose
6-phosphate [22–23] or enzymes of the glucose catabolic pathway, such as glucose kinase, by
exerting transcriptional repression of enzymes involved in the use of glycerol, arabinose,
fructose, and galactose [24].
Glucose and other carbon sources have been found to suppress production of many secondary
metabolites, e.g., actinorhodin in S. lividans [25]. In fact, it was reported that glucose inhibits
actinorhodin production by repressing the transcription of afsR2 that encodes a global
regulatory protein involved in the stimulation of secondary metabolite biosynthesis [25]
(Figure 6).
Figure 6. Effect of glucose on the secondary metabolism in S. lividans.
cAMP, ATP, and adenosine were reported to regulate antibiotic production [26]. When glucose
is the carbon source, inhibition of the cAMP-producing enzyme, adenylate cyclase, occurs and
cAMP levels are low (Figure 7). cAMP is important to activate the transcription factor cAMP
receptor protein (CRP). In the absence of cAMP, CRP does not activate the transcription of
target genes. When glucose is absent, cAMP is accumulated and it forms a complex with CRP,
thereby activating the expression of a large number of genes, including some encoding
enzymes that can supply energy independently from glucose and trigger spore germination,
aerial mycelium formation, and actinorhodin production [27–30]. Extracellular ATP (exATP)
was reported to massively increase actinorhodin and lightly increase undecylprodigiosin
yields in S. coelicolor [31]. The nucleoside adenosine was reported to enhance production of
undecylprodigiosin and conversely to suppress the actinorhodin production [32].
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Figure 7. Effect of glucose on cAMP (blue pentagon) accumulation and antibiotic production in S. coelicolor.
Several microorganisms’ nutrients, such as phosphate and nitrogen compounds, affect the
production of antibiotics and other secondary metabolites. The lack of specific nutrients is
perceived by microorganisms through complex signaling mechanisms. The study of these
pathways is often the key in the understanding of regulatory processes underlying the
synthesis of secondary metabolites.
Streptomycetes sense and respond to the stress of phosphate starvation via the two-component
PhoR-PhoP signal transduction system (Figure 8). In Streptomyces coelicolor, phosphate
negatively controls antibiotic biosynthesis by the two-component PhoR-PhoP system. The
PhoR protein is a membrane sensor kinase, whereas PhoP is a DNA-binding response regulator
(OmpR family). Primary and secondary metabolisms are interconnected. In fact, when S.
coelicolor encounters phosphate limitation in its environment, PhoP activates the transcription
of afsS that positively regulates secondary metabolism biosynthesis through the transcription
of pathway-specific activators, such as actII-ORF4 and redD for actinorhodin and undecylpro‐
digiosin biosynthesis, respectively [33].
The biosynthesis of many antibiotics is very sensitive to phosphate. In Nonomuraea, A40926
production is negatively influenced by phosphate. In particular, phosphate depletion induced
dbv4 transcription that encodes an StrR-like protein, positive regulator of A40926 cluster genes
[34]. In a few cases, phosphate has been reported to have a positive control, i.e., on lantibiotic
production in Firmicutes strains and in Microbispora sp. ATCC-PTA-5024. It was surmised that
phosphate has a different effect on ribosomal and non-ribosomal peptide biosynthesis [35].
A simple strategy to improve antibiotic production is to alter the PhoP concentration, by
disrupting the phoP gene or the phoP-R cluster. In S nataliensis, the mutants obtained showed
an increase of 80% in antibiotic production [36]. However, for some Streptomyces strains, the
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phoP null mutant did not show an antibiotic overproduction, probably because of the com‐
plexity of the network [37].
High concentration of nitrogen sources (such as ammonium or amino acids) also suppress‐
es  the secondary metabolism. Complex fermentation media include proteins as  nitrogen
sources. For example, production of streptomycin antibiotic in S. griseus occurs in soybean
meal with L-proline and low concentration of ammonium salt. Aminoglycoside antibiotic
production is repressed by ammonium salt, while nitrate and certain amino acids stimulate
their production [38].
In S. coelicolor, it was demonstrated that nitrogen assimilation is transcriptionally regulated by
GlnR (Figure 8), which is an orphan response regulator with no coupled sensor kinase [39].
The ΔglnR mutant strain did not grow on nitrate as the sole nitrogen source and showed
reduced growth on ammonium. Furthermore, no production of the pigmented antibiotics
actinorhodin and undecylprodigiosin was observed [40].
Nitrogen metabolism under phosphate control exerted by the binding of PhoP to the promoter
region of glnR reveals that crosstalk between global regulators, such as PhoP and GlnR,
controls the expression of secondary metabolites [41].
Figure 8. Cascade mechanism involved in phosphate control of actinorhodin and undecylprodigiosin biosynthesis in S.
coelicolor.
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In some bacteria of the phylum Actinobacteria, such as S. lividans and S. coelicolor, a shortage
of nitrogen compounds is reflected in the increased concentration of tRNA discharges, a
consequence of the limited availability of amino acids; this phenomenon leads to the activation
of the RelA protein that binds ribosome stalling and allows the synthesis of the nucleotide
pppGpp (guanine 5'- triphosphate 3'-diphosphate). In conditions of nutrient deficiency, there
is a decrease of the GTP pool and the accumulation of pppGpp. pppGpp binds to the RNA
polymerase subunit encoded by the rpoB (RNA polymerase subunit) gene, directing the
transcription of genes important for the production of secondary metabolites. This mechanism
of adaptation to changes in environmental conditions is called "stringent response" [42–43].
7. Genetic engineering
Antibiotic production can be improved by metabolic engineering in several ways. A flux
increase in the biosynthetic pathway can be improved by directed mutagenesis or by elevated
precursor availability. As an example, acetyl-CoA carboxylase was cloned into an expression
vector and introduced into S. coelicolor; the conversion of acetyl-CoA into malonyl-CoA was
enhanced and channeled to actinorhodin production [44]. Similarly, deletion of the pfkA2 gene
that encodes one of the three reported homologs of phosphofructokinase in S. coelicolor and
led to an increased carbon flux through the pentose phosphate pathway increased the
actinorhodin and undecylprodigiosin production four times [24].
In Streptomyces clavuligerus, deletion of the glyceraldehyde 3-phosphate dehydrogenase
encoding gene gap1 improved clavulanic acid production because of increased supply of
precursor glyceraldehyde 3-phosphate [45]. Furthermore, S. coelicolor over-expression of
acetyl-CoA carboxylase improved the yield of actinorhodin, which uses malonyl-CoA as a
precursor for actinorhodin biosynthesis [44]. In S. coelicolor, deletion of citrate synthase or
aconitase led to overproduction of organic acids, as well as changes in secondary metabolite
production and morphological differentiation [46–47]. In Streptomyces lividans, polyphosphate
kinase gene inactivation resulted in the accumulation of polyphosphates and activation of
actinorhodin production, which is normally silenced in this species [48–49].
A promising method to increase antibiotic production is the ribosome engineering developed
by Ochi and colleagues [50]. This method consists of the isolation of spontaneous mutants that
are resistant to sub-lethal levels of antibiotic that targets the ribosomal proteins (such as
streptomycin, gentamicin, kanamicin, cloramphenicol) or the RNA polymerase. Rifampicin
resistance mutation in rpoB and streptomycin resistance mutation in rpsL for the ribosomal
protein S12 led to an increased antibiotic production in S. coelicolor and S. lividans [51].
Some actinomycetes possess two rpoB genes (e.g., Nocardia species), in contrast to the widely
accepted consensus of the existence of a single RNA polymerase in bacteria. In the Nonomur‐
aea sp. strain ATCC 39727, two alleles of RNA polymerase B subunit gene rpoB (rpoB(S) and
rpoB(R)) provide the microorganism with two functionally distinct and developmentally
regulated RNA polymerases [52]. rpoB(R) is characterized by an 18-bp in-frame deletion and
mutations causing five amino acid substitutions located within or close to the so-called rif
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cluster that play a key role in fundamental activities of RNA polymerase. rpoB(R) transcription
is tightly regulated during Nonomuraea growth. Indeed, the expression of the rpoB(R) allele is
growth phase-dependent in the wild type strain: the allele is silent during the pseudo-
exponential phase of growth and begins to be expressed during the transition to the stationary
phase. The merodiploidy might contribute to the developmental strategy of this actinomycete
and the two isoforms may contribute to assemble growth phase-specific variants of RNA
polymerase with different functional properties.
The constitutive expression of rpoB(R) gene in Nonomuraea increased the production of the
glycopeptide antibiotic A40926 in this organism, while the heterologous expression in both
the wild-type Streptomyces lividans strain 1326 and in strain KO-421 (a relaxed mutant unable
to produce ppGpp) markedly activated antibiotic biosynthesis of actinorhodin and undecyl‐
prodigiosin [43].
The basic knowledge of phosphate and nitrogen metabolic pathway can be used for rational
manipulation. For example, amplification of asfR/asfS on a high copy number plasmid led to
overproduction of actinorhodin and undecylprodigiosin in both S. coelicolor and S lividans [53–
54]. In the same way, RelA overexpression leads to an enhanced antibiotic production in S.
coelicolor [55].
8. Secondary metabolism to control antibiotic production
Antibiotic production is controlled at two main levels: pleiotropic regulators controlling the
production of more than one antibiotic and cluster-situated regulator modulating the antibiotic
biosynthetic genes of the cluster in which they are included.
The complex gene cluster for the biosynthesis of each antibiotic usually contains regulatory
and resistance genes. Typically, there may be more than one such pathway-specific regulatory
gene per cluster. Overexpression of positive regulators or deletion of genes that codify for
repressors can be a strategy to improve antibiotic production.
Among the regulatory genes, two-component systems are the most important transduction
signal mechanism in bacteria. Typically, the two-component system comprises a membrane-
bound histidine kinase and a cognate response regulator. The receptor senses specific envi‐
ronmental stimuli, it auto-phosphorylates and activates by phosphorylation the response
regulator that mediates the cellular response, mainly through the transcriptional regulation of
target genes in the cluster for antibiotic [56].
The AbrC1 protein is a histidine kinase part of a two-component system in Streptomyces
coelicolor M145. It is a negative regulator of antibiotic production and morphological differen‐
tiation. Indeed, the deletion of this repressor led to a clear increase in actinorhodin, undecyl‐
prodigiosin, and calcium-dependent antibiotic yields [57].
Other examples of regulators are those of the StrR and LuxR families. StrR was initially
identified in Streptomyces griseus as a pathway specific positive regulator of the expression
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streptomycin biosynthetic gene [58]. LuxR was initially identified in the marine Gram-negative
bacteria Vibrio fisheri, where it regulates the quorum sensing phenomena of bioluminescence
in a population density dependent manner [59]. Proteins of the LuxR family have been
identified among Actinomycetes and two LAL proteins were identified as pleiotropic regula‐
tors affecting various cellular processes in Streptomyces coelicolor [60].
The filamentous actinomycete Nonomuraea sp. strain ATCC39727 codifies for dbv4 and dbv3,
two pathway-specific regulatory genes that code for StrR- and LuxR-type transcriptional
positive regulators, respectively [61]. The over-expression of dbv3 led to a two-fold increase in
the glycopeptide antibiotic A40926 productivity.
The increase of self-resistance levels in producing organisms was used for improving produc‐
tion yields. This strategy was used for S. kanamyceticus and S. fradiae, kanamycin and neomycin
producers, respectively. The 6'-N-acetyltransferase derived from Streptomyces kanamyceticus
strain M1164 was cloned into the high copy plasmid vector pIJ702 and transferred in both
strains. In both cases, transformants containing the recombinant plasmid showed increased
resistance to a number of aminoglycoside antibiotics and substantially increased production
of kanamycin and neomycin [62]. Similar results were described in several antibiotic overpro‐
ducing organisms, such as S. aureofaciens, producer of the chlortetracycline 6-demethylchlor‐
tetracycline, through the overexpression of a self-defense gene involved in drug efflux [63].
To increase the balhimycin production by Amycolatopsis balhimycina, the dahp and pdh genes,
from the biosynthetic cluster that codify for key steps of the shikimate pathway, were over‐
expressed both individually and together. The constructed strains expressing an additional
copy of the dahp gene and the strain carrying an extra copy of both dahp and pdh showed
improved specific glycopeptide productivities by approximately a factor of three [64].
9. γ butyrolactones to control the onset of antibiotic biosynthesis
The production of antibiotics in some Streptomyces spp. depends upon diffusible butyrolactones
structurally similar to homoserine lactones. The most intensively studied is the A factor that
positively controls the pleiotropic regulator AdpA (Figure 9). A factor is gradually produced
by AfsA and it is accumulated in a growth dependent manner [65]. When the concentration
of A-factor reaches a critical level, it binds ArpA, which is released from the promoter of
adpA, thus leading to adpA transcription. The transcriptional activator AdpA then activates a
variety of genes that are required for the biosynthesis of secondary metabolites, including
streptomycin, and morphological differentiation in Streptomyces griseus. Overexpression of
adpA caused S. griseus to produce streptomycin earlier and with a ten-fold higher yield than
the wild-type strain [66].
So far, various γ-butyrolactone molecules, synthases, and receptors have been identified [67–
68].
γ butyrolactones have been applied for improvement of secondary metabolite production. A
factor from S. griseus stimulated antibiotic production in S. natalensis showing an efficient cross-
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talk among different species [69]. Little is known about the use of these small molecules as
global elicitors of antibiotic production, but considering the effect on antibiotic production
even at low concentration, this could be an interesting approach to follow.
10. Heterologous expression of actinomycetes biosynthetic gene clusters
Many antibiotic producing actinomycetes are recalcitrant to manipulation and suitable
protocols for their genetic manipulation are not always available. The transfer of the genetic
information for secondary metabolite production from the original producer to a model host
represents a successful strategy to manipulate biosynthetic gene clusters. Heterologous
expression of large biosynthetic pathways could be also useful in all those cases in which
bacteria are not cultivable or to produce cryptic metabolites, revealed by genome sequencing
and mining. Actinomycetes are characterized by large genomes that are GC-rich [70] and their
genes are not easily expressed in Escherichia coli. To date, several shuttle vectors that can be
maintained in model streptomycetes (Streptomyces coelicolor, S. avermitilis, S. lividans) have been
described, and several libraries have been constructed in bacterial and P1-derived artificial
chromosomes [71–74].
In some cases, a successful heterologous expression of actinomycetes biosynthetic gene clusters
was obtained after changing fermentation conditions, that is, feeding with a biosynthetic
Figure 9. The A-factor regulatory cascade in S. griseus. (A) In the absence of A factor, ArpA binds to the adpA promoter
and represses its transcription. (B) When A factor accumulates and reaches a threshold level, it binds to ArpA that is
detached from the adpA promoter, leading to its expression.
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precursor, minimizing background endogenous activities, or after cloning strong promoters
upstream of production genes weakly transcribed (for a review see [75]). Heterologous
expression in amenable hosts can be useful to exploit and to explore the genetic potential of
actinomycetes.
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